Clinical trial conducted at The ADA Forsyth Institute showed proof-of-concept for IR Scientific’s Sensi-IP technology Somerville, Mass., 02/02/2025 – A clinical trial conducted by the ADA Forsyth Institute, a global leader in oral health research, demonstrated significant reduction in dentin hypersensitivity (DH) from a novel bioactive glass incorporated in a toothpaste. The first-in-human trial established the safety and efficacy of Sensi-IP, a bioactive glass technology developed by IR Scientific. Researchers…